10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
PFIZER INC | ||
Ticker: PFE Fiscal Year: 2015 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2015 10-K (Filed: Feb 29, 2016) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2015 | Dec 31, 2014 | |
| Assets | ||
| Cash and cash equivalents | $ 3,641 | 3,343 |
| Short-term investments | 19,649 | 32,779 |
| Trade accounts receivable, less allowance for doubtful accounts: 2015$384; 2014$412 | 8,176 | 8,401 |
| Inventories | 7,513 | 5,663 [1] |
| Current tax assets | 2,662 | 2,566 |
| Other current assets | 2,163 | 2,843 |
| Total current assets | 43,804 | 55,595 |
| Long-term investments | 15,999 | 17,518 |
| Property, plant and equipment, less accumulated depreciation | 13,766 [2] | 11,762 |
| Identifiable intangible assets, less accumulated amortization | 40,356 | 35,166 |
| Goodwill | 48,242 | 42,069 |
| Noncurrent deferred tax assets and other noncurrent tax assets | 1,794 | 1,944 |
| Other noncurrent assets | 3,499 | 3,513 |
| Total assets | 167,460 | 167,566 |
| Liabilities and Equity | ||
| Short-term borrowings, including current portion of long-term debt: 2015$3,720; 2014$3,011 | 10,160 | 5,141 |
| Trade accounts payable | 3,620 | 3,210 |
| Dividends payable | 1,852 | 1,711 |
| Income taxes payable | 418 | 531 |
| Accrued compensation and related items | 2,359 | 1,841 |
| Other current liabilities | 10,990 | 9,153 |
| Total current liabilities | 29,399 | 21,587 |
| Long-term debt | 28,818 | 31,541 |
| Pension benefit obligations, net | 6,310 [3] | 7,885 |
| Postretirement benefit obligations, net | 1,809 | 2,379 |
| Noncurrent deferred tax liabilities | 26,877 | 23,317 |
| Other taxes payable | 3,992 | 4,353 |
| Other noncurrent liabilities | 5,257 | 4,883 |
| Total liabilities | 102,463 | 95,944 |
| Commitments and Contingencies | ||
| Preferred stock, no par value, at stated value; 27 shares authorized; issued: 2015649; 2014717 | 26 | 29 |
| Common stock, $0.05 par value; 12,000 shares authorized; issued: 20159,178; 20149,110 | 459 | 455 |
| Additional paid-in capital | 81,016 | 78,977 |
| Treasury stock, shares at cost: 20153,003; 20142,819 | (79,252) | (73,021) |
| Retained earnings | 71,993 | 72,176 |
| Accumulated other comprehensive loss | (9,522) | (7,316) |
| Total Pfizer Inc. shareholders equity | 64,720 | 71,301 |
| Equity attributable to noncontrolling interests | 278 | 321 |
| Total equity | 64,998 | 71,622 |
| Total liabilities and equity | 167,460 | 167,566 |
| [1] Increase primarily due to the acquisition of Hospira inventories, which were recorded at fair value. For additional information, see Note 2A. | ||
| [2] The increase in total property, plant and equipment is primarily due to the acquisition of Hospira (see Note 2A) and capital additions, partially offset by depreciation and, to a much lesser extent, impairments, disposals and the impact of foreign exchange. | ||
| [3] Amounts may not add due to rounding. | ||
| External Links | |
| PFIZER INC (PFE) Fiscal Year 2015 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |